Fallopian Tube Cancer
📧 Sign up to get email alerts when something new happens for Fallopian Tube Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2014-12-31Clinical Trial Update: Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy [Phase 3]
A Phase 3 trial of Acetyl-L-Carnitine hydrochloride to prevent chemotherapy-induced peripheral neuropathy in patients with recurrent ovarian…
-
CLINICAL_TRIALS trial_result · 2014-12-25Clinical Trial Update: TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer [Phase 1]
This document reports the completion of a Phase 1 clinical trial evaluating VTX-2337, a TLR8 agonist, in combination with pegylated liposoma…
-
CLINICAL_TRIALS trial_result · 2014-12-15Clinical Trial Update: A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment [Phase 1, Phase 2]
Phase 1/2 study evaluating belinostat in combination with carboplatin and/or paclitaxel in relapsed ovarian cancer; results were posted in 2…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Sunitinib in Recurrent and Refractory Ovarian, Fallopian Tube and Peritoneal Carcinoma [Phase 2]
Phase 2 trial evaluating sunitinib in recurrent and refractory ovarian, fallopian tube, and peritoneal cancer has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2014-11-25Clinical Trial Update: Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer [Phase 2]
A Phase 2 clinical trial evaluating bevacizumab (Avastin) in epithelial ovarian cancer, primary peritoneal cancer, or fallopian tube cancer;…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-11-21Clinical Trial Update: Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma [Phase 2]
Phase 2 trial evaluating Ziv-aflibercept in locally advanced, unresectable, or metastatic gynecologic soft tissue sarcoma has completed with…
-
CLINICAL_TRIALS trial_result · 2014-11-20Clinical Trial Update: BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Cancer [Phase 1]
Phase 1 trial evaluating the safety of BIBF 1120 (nintedanib) in combination with Carboplatin and pegylated liposomal doxorubicin in patient…
-
CLINICAL_TRIALS trial_result · 2014-10-09Clinical Trial Update: S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission [Phase 3]
Phase 3 trial evaluating paclitaxel in patients with advanced ovarian, fallopian tube, or primary peritoneal cancer in remission has complet…
-
CLINICAL_TRIALS trial_result · 2014-10-07Clinical Trial Update: Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [Phase 1]
This completed Phase 1 trial evaluated a combination chemotherapy regimen with autologous peripheral stem cell transplant in patients with s…
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: Effect of Serotonin Level on Constipation Caused by Chemotherapy in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
The clinical trial evaluated whether serotonin level influences chemotherapy-induced constipation in patients with ovarian, fallopian tube, …
-
CLINICAL_TRIALS trial_result · 2014-08-06Clinical Trial Update: Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer [Phase 2]
Phase 2 study of oral ENMD-2076 in ovarian, fallopian tube, and peritoneal cancers has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: A Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma [Phase 2]
A Phase II study evaluated dasatinib (Sprycel) in patients with persistent or recurrent epithelial ovarian, fallopian tube, or primary perit…
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating a combination of docetaxel, trabectedin, and G-CSF or pegfilgrastim in patients with recurrent or persistent ovaria…
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update evaluating topotecan for recurrent ovarian epithelial, fallopian tube, or primary peritoneal cancer, with resu…
-
CLINICAL_TRIALS trial_result · 2014-06-25Clinical Trial Update: Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer [Phase 3]
This entry reports the completion of a Phase 3 trial evaluating carboplatin and paclitaxel with or without gemcitabine in patients with ovar…
-
CLINICAL_TRIALS trial_result · 2014-06-19Clinical Trial Update: Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma [Phase 2]
Phase 2 trial evaluating oxaliplatin, gemcitabine, and bevacizumab in women with recurrent Mullerian carcinomas; the study (NCT00418093) was…
-
CLINICAL_TRIALS trial_result · 2014-06-18Clinical Trial Update: Study of Ramucirumab in Ovarian Cancer [Phase 2]
Phase 2 trial update of ramucirumab in ovarian cancer and related gynecologic cancers has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-06-18Clinical Trial Update: Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
A Phase 2 trial evaluating mifepristone for recurrent or persistent ovarian epithelial, primary peritoneal, or fallopian tube cancer has com…
-
CLINICAL_TRIALS trial_result · 2014-06-12Clinical Trial Update: Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian Cancer [Phase 3]
This Phase 3 trial evaluated early post-operative enteral feeding in patients with advanced epithelial ovarian cancer, including peritoneal …
-
CLINICAL_TRIALS withdrawal · 2014-06-06Clinical Trial Update: A Prospective Trial of COXEN Chemotherapy Prediction [NA]
A prospective trial of COXEN chemotherapy prediction sponsored by the University of Virginia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: Epidural Analgesia or Patient-Controlled Analgesia in Treating Patients Who Have Undergone Surgery for Gynecologic Cancer
A completed clinical trial comparing epidural analgesia versus patient-controlled analgesia for gynecologic cancer surgery, with conditions …
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 2]
A Phase 2 trial evaluating the combination of Bevacizumab and Erlotinib in patients with recurrent or metastatic ovarian epithelial cancer, …
-
CLINICAL_TRIALS trial_result · 2014-03-07Clinical Trial Update: Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase Inhibitor [Phase 2]
Phase 2 randomized multicenter trial evaluating SU11248 (sunitinib) in platinum-refractory epithelial ovarian cancer and peritoneal cancers,…
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: Study of Paclitaxel in Patients With Ovarian Cancer [Phase 3]
A Phase 3 trial evaluating paclitaxel in patients with epithelial ovarian cancer, primary peritoneal cancer, and fallopian tube cancer has c…
-
CLINICAL_TRIALS trial_result · 2014-01-21Clinical Trial Update: Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin [Phase 2]
Phase 2 trial evaluating belinostat plus carboplatin in recurrent or persistent carboplatin/ cisplatin–refractory ovarian epithelial, fallop…